These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers. Chait LD; Johanson CE Psychopharmacology (Berl); 1988; 96(3):302-8. PubMed ID: 3146764 [TBL] [Abstract][Full Text] [Related]
7. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine. Shekim WO; Dekirmenjian H; Chapel JL Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of cocaine and d-amphetamine toxicity with caffeine. Derlet RW; Tseng JC; Albertson TE Am J Emerg Med; 1992 May; 10(3):211-6. PubMed ID: 1586430 [TBL] [Abstract][Full Text] [Related]
9. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome. Gross MD Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283 [No Abstract] [Full Text] [Related]
13. Comparison of behavioral effects of cathinone, amphetamine and apomorphine. Schechter MD; Rosecrans JA; Glennon RA Pharmacol Biochem Behav; 1984 Feb; 20(2):181-4. PubMed ID: 6718445 [TBL] [Abstract][Full Text] [Related]
14. Letter: Alternating caffeine and stimulants. Fras I Am J Psychiatry; 1974 Feb; 131(2):228-9. PubMed ID: 4809054 [No Abstract] [Full Text] [Related]
15. Predicting amphetamine response in hyperkinetic children by electronic pupillography. Knopp W; Arnold LE; Andras RL; Smeltzer DJ Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):158-66. PubMed ID: 4795017 [No Abstract] [Full Text] [Related]
16. Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity. White BC; Keller GE Pharmacol Biochem Behav; 1984 Mar; 20(3):383-6. PubMed ID: 6709673 [TBL] [Abstract][Full Text] [Related]
17. Role of dopamine in d-amphetamine-induced discriminative responding. Ho BT; Huang JT Pharmacol Biochem Behav; 1975; 3(6):1085-92. PubMed ID: 1223898 [TBL] [Abstract][Full Text] [Related]
18. Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism. Sannerud CA; Ator NA J Pharmacol Exp Ther; 1995 Jan; 272(1):100-11. PubMed ID: 7815322 [TBL] [Abstract][Full Text] [Related]
19. Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms. Arnold LE; Wender PH; McCloskey K; Snyder SH Arch Gen Psychiatry; 1972 Dec; 27(6):816-22. PubMed ID: 4564954 [No Abstract] [Full Text] [Related]
20. Growth hormone, prolactin and cortisol responses and growth patterns in hyperkinetic children treated with dextro-amphetamine. Preliminary findings. Puig-Antich J; Greenhill LL; Sassin J; Sachar EJ J Am Acad Child Psychiatry; 1978; 17(3):457-75. PubMed ID: 690355 [No Abstract] [Full Text] [Related] [Next] [New Search]